Stayble Therapeutics board proposes voluntary liquidation and delisting
Shareholders of the research company Stayble Therapeutics are invited to an extraordinary general meeting, also serving as the first meeting for liquidation purposes, on Thursday, May 7, in Gothenburg. As previously announced, the company has prepared a balance sheet for liquidation purposes, which has been audited by the company’s auditor. The balance sheet shows that…

